(Q34610105)

3 August 2017

1 reference

title

Neurohumoral blockade in CHF management (English)

1 reference

3 August 2017

R Willenbrock

1

1 reference

3 August 2017

S Philipp

series ordinal

2

1 reference

3 August 2017

V Mitrovic

series ordinal

3

1 reference

3 August 2017

R Dietz

series ordinal

4

1 reference

3 August 2017

1 September 2000

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

3 August 2017

1 reference

3 August 2017

1 Suppl 1

1 reference

3 August 2017

24-30

1 reference

Acute hemodynamic and renal effects of adrenomedullin in rats with aortocaval shunt.

3 August 2017

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

The angiotensin II type 2 receptor: an enigma with multiple variations

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

The angiotensin type 2 receptor: variations on an enigmatic theme

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

The molecular and cellular pathophysiology of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Neurohormonal activation in patients with mild or moderately severe congestive heart failure and effects of ramipril. The Ramipril Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Key features of candesartan cilexetil and a comparison with other angiotensin II receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Angiotensin inhibition and atrial natriuretic peptide release after acute volume expansion in rats with aortocaval shunt

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: A subgroup analysis from the cooperative north scandinavian enalapril survival study (CONSENSUS)

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.030

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2000.030

0 references

1 reference